ask="2.80"
ask_size="400"
average_daily_volume="957915"
bid="2.40"
bid_size="300"
book_value="1.44"
change="+0.18"
change_from_200_day_moving_average="0.64"
change_from_50_day_moving_average="0.66"
change_from_52_week_high="-2.64"
change_From_52_week_low="1.62"
change_in_percent="+7.38%"
close="2.62"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.92"
ebitda="-8.20M"
eps_estimate_current_year="-0.54"
eps_estimate_next_quarter="-0.24"
eps_estimate_next_year="-0.88"
ex_dividend_date="N/A"
float_shares="4746000"
high="2.64"
high_52_weeks="5.26"
last_trade_date="3/8/2017"
last_trade_price="2.62"
last_trade_size="1286"
last_trade_time="4:00pm"
low="2.43"
low_52_weeks="1.00"
market_capitalization="14.06M"
moving_average_200_day="1.98"
moving_average_50_day="1.96"
name="Cellectar Biosciences
Inc."
notes="N/A"
one_year_target_price="5.27"
open="2.50"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+32.38%"
percent_change_from_50_day_moving_average="+33.61%"
percent_change_from_52_week_high="-50.19%"
percent_change_from_52_week_low="+162.00%"
previous_close="2.44"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.70"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="5368000"
short_ratio="0.78"
stock_exchange="NCM"
symbol="CLRB"
volume="745159"
weeks_range_52="1.00 - 5.26"
